C33H39Cl2N9NiO12, monoclinic, P21/c (no. 14), a = 9.7478(4) Å, b = 20.6247(7) Å, c = 19.0897(11) Å, β = 92.767(5)°, V = 3833.4(3) Å3, Z = 4, Rgt(F) = 0.0527, wRref(F2) = 0.1143, T = 108.4(2) K
Two isostructural NiII compounds, bis{N-[1-(pyridin-2-yl-κN)ethylidene]pyridine-4-carbohydrazonato-κ...
C19H15N3NiO10, monoclinic, P21/c (no. 14), a = 12.7175(10) Å, b = 10.6780(10) Å, c = 15.0802(16) Å, ...
C26H24N2NiO6, hexagonal, P6522 (no. 179), a = b = 11.0161(4) Å, c = 33.1459(8) Å, V = 3483.5(9) Å3, ...
C32H41N7NiO8, monoclinic, P21/c (no. 14), a = 10.0076(5) Å, b = 18.6561(10) Å, c = 19.0893(18) Å, β ...
C26H27ClN8NiO7, triclinic, P1̄ (no. 2), a = 9.893(2) Å, b = 11.503(2) Å, c = 13.295(3) Å, α = 78.77(...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
C25H22Cl2N4O5Zn, monoclinic, P21/c (no. 14), a = 16.302(3) Å, b = 11.324(2) Å, c = 14.636(3) Å, β = ...
C22H28Cl2N4Ni, monoclinic, P21/c (no. 14), a = 9.7332(19) Å, b = 14.886(3) Å, c = 18.623(5) Å, β = 1...
C26H31N5NiO8, monoclinic, P21/n (no. 14), a = 12.554(3) Å, b = 12.401(3) Å, c = 18.718(5) Å, β = 107...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
The mononuclear title complex, [Ni(C50H46N2O4)], crystallizes in the triclinic space group P-1, with...
C18H26N4NiO4, triclinic, P1̄ (no. 2), a = 7.7547(16) Å, b = 7.8666(16) Å, c = 8.2798(17) Å, α = 90.4...
C24H45ClN4NiO7, monoclinic, P21/n (no. 14), a = 10.4947(11) Å, b = 14.3956(13) Å, c = 19.7182(18) Å,...
C16H12Cl2NiN2O2, orthorhombic, Pbca (no. 61), a = 12.5166(12) Å, b = 12.5881(14) Å, c = 19.0086(19) ...
The crystal structure of the title compound, [Ni(C15H 10Cl2-N2O2)(C5H 5N)3]·C5H5N, is built of molec...
Two isostructural NiII compounds, bis{N-[1-(pyridin-2-yl-κN)ethylidene]pyridine-4-carbohydrazonato-κ...
C19H15N3NiO10, monoclinic, P21/c (no. 14), a = 12.7175(10) Å, b = 10.6780(10) Å, c = 15.0802(16) Å, ...
C26H24N2NiO6, hexagonal, P6522 (no. 179), a = b = 11.0161(4) Å, c = 33.1459(8) Å, V = 3483.5(9) Å3, ...
C32H41N7NiO8, monoclinic, P21/c (no. 14), a = 10.0076(5) Å, b = 18.6561(10) Å, c = 19.0893(18) Å, β ...
C26H27ClN8NiO7, triclinic, P1̄ (no. 2), a = 9.893(2) Å, b = 11.503(2) Å, c = 13.295(3) Å, α = 78.77(...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
C25H22Cl2N4O5Zn, monoclinic, P21/c (no. 14), a = 16.302(3) Å, b = 11.324(2) Å, c = 14.636(3) Å, β = ...
C22H28Cl2N4Ni, monoclinic, P21/c (no. 14), a = 9.7332(19) Å, b = 14.886(3) Å, c = 18.623(5) Å, β = 1...
C26H31N5NiO8, monoclinic, P21/n (no. 14), a = 12.554(3) Å, b = 12.401(3) Å, c = 18.718(5) Å, β = 107...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
The mononuclear title complex, [Ni(C50H46N2O4)], crystallizes in the triclinic space group P-1, with...
C18H26N4NiO4, triclinic, P1̄ (no. 2), a = 7.7547(16) Å, b = 7.8666(16) Å, c = 8.2798(17) Å, α = 90.4...
C24H45ClN4NiO7, monoclinic, P21/n (no. 14), a = 10.4947(11) Å, b = 14.3956(13) Å, c = 19.7182(18) Å,...
C16H12Cl2NiN2O2, orthorhombic, Pbca (no. 61), a = 12.5166(12) Å, b = 12.5881(14) Å, c = 19.0086(19) ...
The crystal structure of the title compound, [Ni(C15H 10Cl2-N2O2)(C5H 5N)3]·C5H5N, is built of molec...
Two isostructural NiII compounds, bis{N-[1-(pyridin-2-yl-κN)ethylidene]pyridine-4-carbohydrazonato-κ...
C19H15N3NiO10, monoclinic, P21/c (no. 14), a = 12.7175(10) Å, b = 10.6780(10) Å, c = 15.0802(16) Å, ...
C26H24N2NiO6, hexagonal, P6522 (no. 179), a = b = 11.0161(4) Å, c = 33.1459(8) Å, V = 3483.5(9) Å3, ...